Author

Klaas Nico Faber 1

1 University of Groningen, University Medical Center Groningen,Groningen,Netherlands

ANTI-INFLAMMATORY ACTIONS OF BUTYRATE ON MACROPHAGES AND EPITHELIAL CELLS IN INTESTINAL MUCOSA OF INFLAMMATORY BOWEL DISEASE PATIENTS

Daniela Parada Venegas, Marjorie K. De la Fuente, Tjasso Blokzijl, Yingying Cui, Daniela Simian, Hermie J.M. Harmsen, RODRIGO QUERA, Gerard Dijkstra, Klaas Nico Faber, Marcela Hermoso

BIOMARKERS REFLECTING EXTRACELLULAR MATRIX TURNOVER AND INFLAMMATION CAN BE USED TO MONITOR DISEASE ACTIVITY AND TREATMENT RESPONSE IN PATIENTS WITH CROHN’S DISEASE UNDERGOING INFLIXIMAB INDUCTION THERAPY

Marta Sorokina Alexdóttir, Arno R. Bourgonje, Morten Asser Karsdal, Anne-Christine Bay-Jensen, Klaas Nico Faber, Roberta Loveikyte, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Gerard Dijkstra, Joachim Mortensen

Combining absolute quantification of fecal bacteria with metagenomic sequencing data improves the characterization of the gut microbiome of patients with Crohn's disease

Arnau Vich Vila, Anna Boddeke, Alexander Kurilshikov, Valerie Collij, Paula Sureda Horrach, Julius Z. H. von Martels, Arno R. Bourgonje, Marjolein Anthonia Ymkje Klaassen, Shixian Hu, Dianne B.H Jansen, Klaas Nico Faber, Gerard Dijkstra, Alexandra Zhernakova, Hermie J. M. Harmsen, Rinse K. Weersma

Eotaxin-1 and mucosal eosinophil abundance predict treatment response to vedolizumab in Inflammatory Bowel Disease

Ruben Yannick Gabriëls, Arno R. Bourgonje, Julius Z. H. von Martels, Guido Trentadue, Tjasso Blokzijl, Hendrik M. van Dullemen, Eleonora A. M. Festen, Marijn C. Visschedijk, Rinse K. Weersma, Gursah Kats-Ugurlu, Klaas Nico Faber, Gerard Dijkstra

FAECALIBACTERIUM PRAUSNITZII MODULATES INTESTINAL MUCOSAL HEALTH VIA HIF1ALPHA-INDUCED EPITHELIAL PRODUCTION OF IL-18

Raphael Fagundes Rosa, Gabriela Bravo Ruiseco Sanchez, Shixian Hu, Rinse K. Weersma, Cormac T. Taylor, Hermie J. M. Harmsen, Klaas Nico Faber, Gerard Dijkstra

INULIN-GROWN FAECALIBACTERIUM PRAUSNITZII CROSS-FEEDS THE HUMAN INTESTINAL EPITHELIUM WITH FRUCTOSE

Raphael Fagundes Rosa, Ali Saeed, Arnau Vich Vila, Arno R. Bourgonje, Mehdi Sadaghian Sadabad, Sander S. van Leeuwen, Hermie J. M. Harmsen, Klaas Nico Faber, Gerard Dijkstra, Julius Z. H. von Martels, Rinse K. Weersma

Levels of serum free thiols are superior to fecal calprotectin in predicting endoscopic disease activity in Inflammatory Bowel Disease

Arno R. Bourgonje, Ruben Y. Gabriëls, Martin H. de Borst, Marian L. C. Bulthuis, Klaas Nico Faber, Harry van Goor, Gerard Dijkstra

Riboflavin suppresses inflammation and attenuates Crohn's disease symptoms (RISE-UP Study)

Julius Z. H. von Martels, Arno R. Bourgonje, Marjolein A. Y. Klaassen, Hassan A. A. Alkhalifah, Mehdi Sadaghian Sadabad, Arnau Vich Vila, Ranko Gacesa, Ruben Y. Gabriëls, Robert E. Steinert, Bernadien H. Jansen, Marian L. C. Bulthuis, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Pa

SEROLOGICAL BIOMARKERS OF TYPE III AND IV COLLAGEN REMODELING PREDICT AND MONITOR INFLIXIMAB TREATMENT RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Marta Sorokina Alexdóttir, Arno R. Bourgonje, Anne-Christine Bay-Jensen, Klaas Nico Faber, Morten Asser Karsdal, Roberta Loveikyte, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Gerard Dijkstra, Joachim Mortensen

STUDYING THE MUTUAL INTERACTION BETWEEN THE HUMAN GUT EPITHELIUM AND THE PREDOMINANTLY ANAEROBIC GUT MICROBIOME IN HOXBAN-STOOL

Gabriela Bravo Ruiseco Sanchez, Ali Saeed, Hermie J. M. Harmsen, Klaas Nico Faber, Yuchen Yang, Raphael Fagundes Rosa

Item 1 - 10 / 15
1
2